Mazzacco Catherine 4
4 · Krystal Biotech, Inc. · Filed Jul 1, 2024
Insider Transaction Report
Form 4
Mazzacco Catherine
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-30+5,000→ 5,000 totalExercise: $183.64Exp: 2034-06-30→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]The options were awarded on June 30, 2024 and vest in equal monthly tranches over a one-year period.